A top Novartis executive says the $225 billion drug giant is planning for a ‘doomsday scenario’ in cancer treatment (NVS)
|01/23/2019||Posted by BusinessMediaguide.Com under General World News||
- Swiss drug giant Novartis is developing drugs that could prevent cancer before patients get it.
- Jay Bradner, who heads up Novartis’s drug research and discovery, says that in a “doomsday” scenario, this may end up being the only cure for cancer.
- But health insurers might not want to pay for preventative cancer drugs because they won’t benefit from future savings, Bradner said.
- Bradner spoke with Business Insider at the World Economic Forum in Davos, Switzerland this week.
DAVOS, Switzerland — Cancer drugs today work to fight off the most serious forms of the disease.